144 related articles for article (PubMed ID: 35503453)
1. Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma.
Karg MM; John L; Refaian N; Buettner C; Rottmar T; Sommer J; Bock B; Resheq YJ; Ksander BR; Heindl LM; Mackensen A; Bosch JJ
Mol Cancer Res; 2022 Aug; 20(8):1320-1336. PubMed ID: 35503453
[TBL] [Abstract][Full Text] [Related]
2. Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype.
Ho AL; Musi E; Ambrosini G; Nair JS; Deraje Vasudeva S; de Stanchina E; Schwartz GK
PLoS One; 2012; 7(7):e40439. PubMed ID: 22808163
[TBL] [Abstract][Full Text] [Related]
3. Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma.
Gao MZ; Wang HB; Chen XL; Cao WT; Fu L; Li Y; Quan HT; Xie CY; Lou LG
Acta Pharmacol Sin; 2019 Feb; 40(2):268-278. PubMed ID: 29777202
[TBL] [Abstract][Full Text] [Related]
4. Metastatic disease from uveal melanoma: treatment options and future prospects.
Carvajal RD; Schwartz GK; Tezel T; Marr B; Francis JH; Nathan PD
Br J Ophthalmol; 2017 Jan; 101(1):38-44. PubMed ID: 27574175
[TBL] [Abstract][Full Text] [Related]
5. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.
Olmeda D; Cerezo-Wallis D; Riveiro-Falkenbach E; Pennacchi PC; Contreras-Alcalde M; Ibarz N; Cifdaloz M; Catena X; Calvo TG; Cañón E; Alonso-Curbelo D; Suarez J; Osterloh L; Graña O; Mulero F; Megías D; Cañamero M; Martínez-Torrecuadrada JL; Mondal C; Di Martino J; Lora D; Martinez-Corral I; Bravo-Cordero JJ; Muñoz J; Puig S; Ortiz-Romero P; Rodriguez-Peralto JL; Ortega S; Soengas MS
Nature; 2017 Jun; 546(7660):676-680. PubMed ID: 28658220
[TBL] [Abstract][Full Text] [Related]
6. Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.
Amirouchene-Angelozzi N; Nemati F; Gentien D; Nicolas A; Dumont A; Carita G; Camonis J; Desjardins L; Cassoux N; Piperno-Neumann S; Mariani P; Sastre X; Decaudin D; Roman-Roman S
Mol Oncol; 2014 Dec; 8(8):1508-20. PubMed ID: 24994677
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target.
Bao R; Surriga O; Olson DJ; Allred JB; Strand CA; Zha Y; Carll T; Labadie BW; Bastos BR; Butler M; Hogg D; Musi E; Ambrosini G; Munster P; Schwartz GK; Luke JJ
Melanoma Res; 2021 Feb; 31(1):27-37. PubMed ID: 33170593
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.
Calipel A; Landreville S; De La Fouchardière A; Mascarelli F; Rivoire M; Penel N; Mouriaux F
Clin Exp Metastasis; 2014 Jun; 31(5):553-64. PubMed ID: 24652072
[TBL] [Abstract][Full Text] [Related]
9. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects.
Baggetto LG; Gambrelle J; Dayan G; Labialle S; Barakat S; Michaud M; Grange JD; Gayet L
Cancer Treat Rev; 2005 Aug; 31(5):361-79. PubMed ID: 15994016
[TBL] [Abstract][Full Text] [Related]
10. Neddylation Blockade Diminishes Hepatic Metastasis by Dampening Cancer Stem-Like Cells and Angiogenesis in Uveal Melanoma.
Jin Y; Zhang P; Wang Y; Jin B; Zhou J; Zhang J; Pan J
Clin Cancer Res; 2018 Aug; 24(15):3741-3754. PubMed ID: 29233905
[No Abstract] [Full Text] [Related]
11. Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model.
Surriga O; Rajasekhar VK; Ambrosini G; Dogan Y; Huang R; Schwartz GK
Mol Cancer Ther; 2013 Dec; 12(12):2817-26. PubMed ID: 24140933
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel chemotherapeutic strategies for metastatic uveal melanoma.
Fagone P; Caltabiano R; Russo A; Lupo G; Anfuso CD; Basile MS; Longo A; Nicoletti F; De Pasquale R; Libra M; Reibaldi M
Sci Rep; 2017 Mar; 7():44564. PubMed ID: 28303962
[TBL] [Abstract][Full Text] [Related]
13. Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma.
Cheng H; Terai M; Kageyama K; Ozaki S; McCue PA; Sato T; Aplin AE
Cancer Res; 2015 Jul; 75(13):2737-48. PubMed ID: 25952648
[TBL] [Abstract][Full Text] [Related]
14. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
[TBL] [Abstract][Full Text] [Related]
15. Metastatic uveal melanoma: biology and emerging treatments.
Woodman SE
Cancer J; 2012; 18(2):148-52. PubMed ID: 22453016
[TBL] [Abstract][Full Text] [Related]
16. Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal Melanoma.
Patel RP; Thomas JR; Curt KM; Fitzsimmons CM; Batista PJ; Bates SE; Gottesman MM; Robey RW
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):16. PubMed ID: 34533562
[TBL] [Abstract][Full Text] [Related]
17. Uveal melanoma.
Spagnolo F; Caltabiano G; Queirolo P
Cancer Treat Rev; 2012 Aug; 38(5):549-53. PubMed ID: 22270078
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism array analysis of uveal melanomas reveals that amplification of CNKSR3 is correlated with improved patient survival.
Lake SL; Damato BE; Kalirai H; Dodson AR; Taktak AF; Lloyd BH; Coupland SE
Am J Pathol; 2013 Mar; 182(3):678-87. PubMed ID: 23357503
[TBL] [Abstract][Full Text] [Related]
19. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.
Ambrosini G; Pratilas CA; Qin LX; Tadi M; Surriga O; Carvajal RD; Schwartz GK
Clin Cancer Res; 2012 Jul; 18(13):3552-61. PubMed ID: 22550165
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal 3 and 8 status within hepatic metastasis of uveal melanoma.
Singh AD; Tubbs R; Biscotti C; Schoenfield L; Trizzoi P
Arch Pathol Lab Med; 2009 Aug; 133(8):1223-7. PubMed ID: 19653714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
